Related references
Note: Only part of the references are listed.Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation
Kathrin Meyer et al.
HUMAN MOLECULAR GENETICS (2009)
Deletion of smn-1, the Caenorhabditis elegans ortholog of the spinal muscular atrophy gene, results in locomotor dysfunction and reduced lifespan
Michael Briese et al.
HUMAN MOLECULAR GENETICS (2009)
Impaired Synaptic Vesicle Release and Immaturity of Neuromuscular Junctions in Spinal Muscular Atrophy Mice
Lingling Kong et al.
JOURNAL OF NEUROSCIENCE (2009)
DcpS as a Therapeutic Target for Spinal Muscular Atrophy
Jasbir Singh et al.
ACS CHEMICAL BIOLOGY (2008)
Sustained Improvement of Spinal Muscular Atrophy Mice Treated with Trichostatin A Plus Nutrition
Heather L. Narver et al.
ANNALS OF NEUROLOGY (2008)
Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect
Tatiana O. Gavrilina et al.
HUMAN MOLECULAR GENETICS (2008)
Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy
Shingo Kariya et al.
HUMAN MOLECULAR GENETICS (2008)
Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy
John Thurmond et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Detection of human survival motor neuron (SMN) protein in mice containing the SMN2 transgene: Applicability to preclinical therapy development for spinal muscular atrophy
Virginia B. Mattis et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
The effect of hydroxyurea in spinal muscular atrophy cells and patients
Wen-Chen Liang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Modeling Spinal Muscular Atrophy in Drosophila
Howard Chia-Hao Chang et al.
PLOS ONE (2008)
DcpS, a general modulator of cap-binding protein-dependent processes?
Sophie Bail et al.
RNA BIOLOGY (2008)
Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy
Lyndsay M. Murray et al.
HUMAN MOLECULAR GENETICS (2008)
Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing
Tatyana Novoyatleva et al.
HUMAN MOLECULAR GENETICS (2008)
Induction of full-length survival motor neuron by polyphenol botanical compounds
Mary S. Sakla et al.
HUMAN GENETICS (2008)
A small-molecule therapeutic lead for Huntington's disease: Preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse
Vanita Chopra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Ribonucleoprotein Assembly Defects Correlate with Spinal Muscular Atrophy Severity and Preferentially Affect a Subset of Spliceosomal snRNPs
Francesca Gabanella et al.
PLOS ONE (2007)
Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy
Matthew E. R. Butchbach et al.
NEUROBIOLOGY OF DISEASE (2007)
A novel method for oral delivery of drug compounds to the neonatal SMNΔ7 mouse model of spinal muscular atrophy
Matthew E. R. Butchbach et al.
JOURNAL OF NEUROSCIENCE METHODS (2007)
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy
Amy M. Avila et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
A Drosophila melanogaster model of spinal muscular atrophy reveals a function for SMN in striated muscle
T. K. Rajendra et al.
JOURNAL OF CELL BIOLOGY (2007)
Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with SMA
L. R. Simard et al.
NEUROLOGY (2007)
Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts
Virginia B. Mattis et al.
HUMAN GENETICS (2006)
The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells
Markus Riessland et al.
HUMAN GENETICS (2006)
A feasibility study for the newborn screening of spinal muscular atrophy
Robert E. Pyatt et al.
GENETICS IN MEDICINE (2006)
In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy
E Hahnen et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells
SM Grzeschik et al.
ANNALS OF NEUROLOGY (2005)
The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation
F Gabanella et al.
HUMAN MOLECULAR GENETICS (2005)
Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy
J Jarecki et al.
HUMAN MOLECULAR GENETICS (2005)
The survival of motor neurons protein determines the capacity for snRNP assembly: Biochemical deficiency in spinal muscular atrophy
LL Wan et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels
EC Wolstencroft et al.
HUMAN MOLECULAR GENETICS (2005)
SMNΔ7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN
TT Le et al.
HUMAN MOLECULAR GENETICS (2005)
A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo
XQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Characterization of the survival motor neuron (SMN) promoter provides evidence for complex combinatorial regulation in undifferentiated and differentiated P19 cells
RL Rouget et al.
BIOCHEMICAL JOURNAL (2005)
被撤回的出版物: Identification of a novel cyclic AMP-response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene (Retracted article. See vol. 293, pg. 12946, 2018)
S Majumder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells
B Boda et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2004)
Deletion of murine Smn Exon 7 directed to liver leads to severe defect of liver development associated with iron overload
JM Vitte et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism
MR Lunn et al.
CHEMISTRY & BIOLOGY (2004)
Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy
C Andreassi et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2004)
Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy
L Brichta et al.
HUMAN MOLECULAR GENETICS (2003)
Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding
ML McWhorter et al.
JOURNAL OF CELL BIOLOGY (2003)
Neuromuscular defects in a Drosophila survival motor neuron gene mutant
YB Chan et al.
HUMAN MOLECULAR GENETICS (2003)
Intact satellite cells lead to remarkable protection against Smn gene defect in differentiated skeletal muscle
S Nicole et al.
JOURNAL OF CELL BIOLOGY (2003)
Valproic acid increases SMN levels in spinal muscular atrophy patient cells
CJ Sumner et al.
ANNALS OF NEUROLOGY (2003)
Biochemical and clinical aspects of methotrexate neurotoxicity
S Vezmar et al.
CHEMOTHERAPY (2003)
Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model
C Cifuentes-Diaz et al.
HUMAN MOLECULAR GENETICS (2002)
Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer
RW Johnstone
NATURE REVIEWS DRUG DISCOVERY (2002)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients
C Andreassi et al.
HUMAN MOLECULAR GENETICS (2001)
An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA
ML Zhang et al.
GENE THERAPY (2001)
Treatment of spinal muscular atrophy by sodium butyrate
JG Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells
PJ Young et al.
EXPERIMENTAL CELL RESEARCH (2000)
The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn-/- mice and results in a mouse with spinal muscular atrophy
UR Monani et al.
HUMAN MOLECULAR GENETICS (2000)
A mouse model for spinal muscular atrophy
HM Hsieh-Li et al.
NATURE GENETICS (2000)